Comparison of Goniotomy Device Outcomes in Combined Phacoemulsification-goniotomy Surgeries
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHenry Ford Health System
About this trial
The goal of this study is to determine of one of three different devices to perform goniotomy to treat glaucoma at the time of cataract surgery is more or less effective than the others. The primary outcomes are to compare intraocular pressure control and glaucoma medication use up to 6 months after surgery. Participants will under combined cataract surgery and goniotomy. They will have post-operative follow up visits at 1 day, 1 week, 1 month, 3 months, and 6 month
Eligibility criteria
Qualifiers
Diagnosed with primary or secondary open-angle glaucoma (e.g., POAG, pigmentary, pseudoexfoliative)
Scheduled for phacoemulsification with planned goniotomy
Able to provide informed consent
Disqualifiers
Angle-closure glaucoma
Prior glaucoma surgery in the study eye
Planned stand-alone goniotomy
Inability to comply with follow-up schedule
Trial design
Treatments tested in this trial
- Goniotomy
Treatment groups
132 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov